Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors (Q46239526)
Jump to navigation
Jump to search
scientific article published on 18 November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors |
scientific article published on 18 November 2008 |
Statements
1 reference
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors (English)
1 reference
1 reference
Camilo Jimenez
1 reference
Maria E Cabanillas
1 reference
Eric Jonasch
1 reference
Karen L Kyle
1 reference
Elizabeth A Lano
1 reference
Surena F Matin
1 reference
Rodolfo F Nunez
1 reference
Nancy D Perrier
1 reference
Alexandria Phan
1 reference
Thereasa A Rich
1 reference
Beejal Shah
1 reference
18 November 2008
1 reference
94
1 reference
2
1 reference
386-391
1 reference
Identifiers
1 reference